337 related articles for article (PubMed ID: 27592281)
1. Citral reduces breast tumor growth by inhibiting the cancer stem cell marker ALDH1A3.
Thomas ML; de Antueno R; Coyle KM; Sultan M; Cruickshank BM; Giacomantonio MA; Giacomantonio CA; Duncan R; Marcato P
Mol Oncol; 2016 Nov; 10(9):1485-1496. PubMed ID: 27592281
[TBL] [Abstract][Full Text] [Related]
2. Essential role of aldehyde dehydrogenase 1A3 for the maintenance of non-small cell lung cancer stem cells is associated with the STAT3 pathway.
Shao C; Sullivan JP; Girard L; Augustyn A; Yenerall P; Rodriguez-Canales J; Liu H; Behrens C; Shay JW; Wistuba II; Minna JD
Clin Cancer Res; 2014 Aug; 20(15):4154-66. PubMed ID: 24907115
[TBL] [Abstract][Full Text] [Related]
3. Aldehyde dehydrogenase activity of breast cancer stem cells is primarily due to isoform ALDH1A3 and its expression is predictive of metastasis.
Marcato P; Dean CA; Pan D; Araslanova R; Gillis M; Joshi M; Helyer L; Pan L; Leidal A; Gujar S; Giacomantonio CA; Lee PW
Stem Cells; 2011 Jan; 29(1):32-45. PubMed ID: 21280157
[TBL] [Abstract][Full Text] [Related]
4. Aldehyde dehydrogenase 1A3 influences breast cancer progression via differential retinoic acid signaling.
Marcato P; Dean CA; Liu RZ; Coyle KM; Bydoun M; Wallace M; Clements D; Turner C; Mathenge EG; Gujar SA; Giacomantonio CA; Mackey JR; Godbout R; Lee PW
Mol Oncol; 2015 Jan; 9(1):17-31. PubMed ID: 25106087
[TBL] [Abstract][Full Text] [Related]
5. ALDH1A3-mTOR axis as a therapeutic target for anticancer drug-tolerant persister cells in gastric cancer.
Kawakami R; Mashima T; Kawata N; Kumagai K; Migita T; Sano T; Mizunuma N; Yamaguchi K; Seimiya H
Cancer Sci; 2020 Mar; 111(3):962-973. PubMed ID: 31960523
[TBL] [Abstract][Full Text] [Related]
6. In Vivo Anti-Tumor Effects of Citral on 4T1 Breast Cancer Cells via Induction of Apoptosis and Downregulation of Aldehyde Dehydrogenase Activity.
Nigjeh SE; Yeap SK; Nordin N; Rahman H; Rosli R
Molecules; 2019 Sep; 24(18):. PubMed ID: 31492037
[TBL] [Abstract][Full Text] [Related]
7. Transcriptomic Analysis of Breast Cancer Stem Cells and Development of a pALDH1A1:mNeptune Reporter System for Live Tracking.
Bidan N; Bailleul-Dubois J; Duval J; Winter M; Denoulet M; Hannebicque K; El-Sayed IY; Ginestier C; Forissier V; Charafe-Jauffret E; Macario M; Matsunaga YT; Meignan S; Anquez F; Julien S; Bonnefond A; Derhourhi M; Le Bourhis X; Lagadec C
Proteomics; 2019 Nov; 19(21-22):e1800454. PubMed ID: 31430054
[TBL] [Abstract][Full Text] [Related]
8. Citral induced apoptosis in MDA-MB-231 spheroid cells.
Nigjeh SE; Yeap SK; Nordin N; Kamalideghan B; Ky H; Rosli R
BMC Complement Altern Med; 2018 Feb; 18(1):56. PubMed ID: 29433490
[TBL] [Abstract][Full Text] [Related]
9. Combination therapy with epigenetic-targeted and chemotherapeutic drugs delivered by nanoparticles to enhance the chemotherapy response and overcome resistance by breast cancer stem cells.
Li SY; Sun R; Wang HX; Shen S; Liu Y; Du XJ; Zhu YH; Jun W
J Control Release; 2015 May; 205():7-14. PubMed ID: 25445694
[TBL] [Abstract][Full Text] [Related]
10. ALDH1A3-regulated long non-coding RNA NRAD1 is a potential novel target for triple-negative breast tumors and cancer stem cells.
Vidovic D; Huynh TT; Konda P; Dean C; Cruickshank BM; Sultan M; Coyle KM; Gujar S; Marcato P
Cell Death Differ; 2020 Jan; 27(1):363-378. PubMed ID: 31197235
[TBL] [Abstract][Full Text] [Related]
11. Identification of Breast Cancer Stem Cells Using a Newly Developed Long-acting Fluorescence Probe, C5S-A, Targeting ALDH1A1.
Okamoto A; Funakoshi Y; Oe M; Takai R; Suto H; Nagatani Y; Nishimura M; Imamura Y; Kunihisa T; Kiyota N; Miki K; Ohe K; Tanino H; Minami H
Anticancer Res; 2022 Mar; 42(3):1199-1205. PubMed ID: 35220209
[TBL] [Abstract][Full Text] [Related]
12. PGE
Lin MC; Chen SY; He PL; Herschman H; Li HJ
Int J Cancer; 2018 Sep; 143(6):1440-1455. PubMed ID: 29658109
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of breast cancer growth via miR-7 suppressing ALDH1A3 activity concomitant with decreasing breast cancer stem cell subpopulation.
Pan M; Li M; You C; Zhao F; Guo M; Xu H; Li L; Wang L; Dou J
J Cell Physiol; 2020 Feb; 235(2):1405-1416. PubMed ID: 31347176
[TBL] [Abstract][Full Text] [Related]
14. The stem cell/cancer stem cell marker ALDH1A3 regulates the expression of the survival factor tissue transglutaminase, in mesenchymal glioma stem cells.
Sullivan KE; Rojas K; Cerione RA; Nakano I; Wilson KF
Oncotarget; 2017 Apr; 8(14):22325-22343. PubMed ID: 28423611
[TBL] [Abstract][Full Text] [Related]
15. Differential Functional Roles of ALDH1A1 and ALDH1A3 in Mediating Metastatic Behavior and Therapy Resistance of Human Breast Cancer Cells.
Croker AK; Rodriguez-Torres M; Xia Y; Pardhan S; Leong HS; Lewis JD; Allan AL
Int J Mol Sci; 2017 Sep; 18(10):. PubMed ID: 28937653
[TBL] [Abstract][Full Text] [Related]
16. Identification of ALDH1A3 as a Viable Therapeutic Target in Breast Cancer Metastasis-Initiating Cells.
Yamashita D; Minata M; Ibrahim AN; Yamaguchi S; Coviello V; Bernstock JD; Harada S; Cerione RA; Tannous BA; La Motta C; Nakano I
Mol Cancer Ther; 2020 May; 19(5):1134-1147. PubMed ID: 32127468
[TBL] [Abstract][Full Text] [Related]
17. Metabolite profiling reveals a connection between aldehyde dehydrogenase 1A3 and GABA metabolism in breast cancer metastasis.
Dahn ML; Walsh HR; Dean CA; Giacomantonio MA; Fernando W; Murphy JP; Walker OL; Wasson MD; Gujar S; Pinto DM; Marcato P
Metabolomics; 2022 Jan; 18(1):9. PubMed ID: 34989902
[TBL] [Abstract][Full Text] [Related]
18. Sulforaphane, a dietary component of broccoli/broccoli sprouts, inhibits breast cancer stem cells.
Li Y; Zhang T; Korkaya H; Liu S; Lee HF; Newman B; Yu Y; Clouthier SG; Schwartz SJ; Wicha MS; Sun D
Clin Cancer Res; 2010 May; 16(9):2580-90. PubMed ID: 20388854
[TBL] [Abstract][Full Text] [Related]
19. High expression of ALDH1A3 might independently influence poor progression-free and overall survival in patients with glioma via maintaining glucose uptake and lactate production.
Ni W; Xia Y; Luo L; Wen F; Hu D; Bi Y; Qi J
Cell Biol Int; 2020 Feb; 44(2):569-582. PubMed ID: 31642564
[TBL] [Abstract][Full Text] [Related]
20. ALDH1A isozymes are markers of human melanoma stem cells and potential therapeutic targets.
Luo Y; Dallaglio K; Chen Y; Robinson WA; Robinson SE; McCarter MD; Wang J; Gonzalez R; Thompson DC; Norris DA; Roop DR; Vasiliou V; Fujita M
Stem Cells; 2012 Oct; 30(10):2100-13. PubMed ID: 22887839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
